Two points to consider about the effects of the weight loss medication trial. A reduction in apnoea episodes does not necessarily translate into not needing a cpap machine. Also a short term benefit does not necessarily translate into a long term benefit. For example a significant number of people having bariatric surgery for weight loss that initially lose large amounts of weight put it back on as the years go by. This is a good result for weight loss medication but the impact on RMD is not necessarily substantial.
Buy RMD now and get great upside returns in a year or two, page-134
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$28.64 |
Change
-0.140(0.49%) |
Mkt cap ! $18.15B | |||
| Open | High | Low | Value | Volume |
| $28.51 | $28.73 | $28.51 | $35.29M | 1.233M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9450 | $28.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $28.64 | 107 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| RMD (ASX) Chart |